Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
Melo
Ailton
A
Rodrigues
Bernardo
B
Nóbrega
Ana Caline
AC
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D020734:Parkinsonian Disorders / Q000150:complications*; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A